Join BOPA
Back to news articles

SURVEY: Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma

By BOPA research committee on 10th February 2025

Help Improve Bispecific Antibody Delivery for Multiple Myeloma Patients!

The Consensus Framework for the Optimal Delivery of Bispecific Antibodies for Patients with Multiple Myeloma was published November 2024. Created by the Equity in Multiple Myeloma Bispecific Research and Access (EMMBRAce) Bispecific Antibody Implementation Group, aims to enhance the delivery and accessibility of bispecific antibodies for patients with multiple myeloma.

 

📄 Read the Consensus Framework here: Consensus Framework Document 

 

The EMMBRAce group would like your feedback to refine this framework and project, ultimately improving treatment options for patients. Please take a moment to complete the survey and share it with your network.

 

🗓️ Survey Closes: February 27th

 

🔗 Take the Survey: https://qualtrics.ucl.ac.uk/jfe/form/SV_0Ilnj2WKuNB9lEa

 

Thank you for your valuable input and support!

Latest News

By NHS Infusions and Special Medicines Programme on 4th September 2026

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications

Expressions of interest for Expert Panel Sub Group to support the approval and implementation of Standardised Product Specifications The Infusions and Special Medicines Programme is inviting expressions of interest for…

Read article
By BOPA on 31st August 2026

🌟 BOPA Advanced Pharmacist Study Day – Elevate Your Practice, Shape Your Career

Are you an oncology or haematology pharmacist with around five or more years of experience — whether Band 7 or Band 8 — and ready to take the next step…

Read article
By BOPA Executive Committee on 31st August 2026

BOPA 2026 Executive Committee Election – One week left to cast your vote

One week left to cast your vote for the BOPA Executive Committee Election. Have your say at BOPA’s future.   In 2026 we received 9 nominations for 6 positions. -Standard…

Read article
By BOPA Executive Committee on 27th August 2026

UK multidisciplinary Consensus Document – Safe Management of Hazardous Medicinal Products in UK Healthcare Settings

We are pleased to jointly publish the new UK multidisciplinary consensus document, Safe Management of Hazardous Medicinal Products in UK Healthcare Settings. Hazardous medicinal products (HMPs) are used across a…

Read article